Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $1,874 | $0 |
| + Debt | $0 | $0 | $5,594 | $0 |
| Enterprise Value | $0 | $0 | $3,720 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$40,151 | -$113,683 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$39,684 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.08 | -0.84 | -705,301.71 | -2.16 |
| % Growth | -28.6% | 100% | -32,652,756.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$11,775 | -$0 |
| Capital Expenditures | $0 | -$0 | -$30 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$11,804 | -$0 |